CD8A and neoplasm: As for lung adenocarcinoma, the differentiation of tumor-specific CD4+ T follicular helper cells under the stimulation of B cells in a neoantigen-dependent manner, which promote CD8+ T cell effector functions and drive anti-tumor immunity [106].